Posttransfusion purpura: therapeutic failure of PlAl-negative platelet transfusion.
The effect of platelet type-specific transfusion in posttranfusion purpura is reported. Seven days after receiving 4 units of whole blood during total hip replacement a 69-year-old woman developed fulminant thrombocytopenic purpura. Her undiluted serum inhibited the clot retraction of PlAl-positive but not PlAl-negative blood. Anti-PlAl titer of her serum, determined by 51Cr platelet lysis technique, was 1:64. The serum had no lytic activity against platelet-rich plasma from two PlAl-negative donors. No anti-HLA antibody was detectable in the serum by lymphocytotoxicity technique, and serum obtained prior to transfusions had no platelet lytic activity. Four units of PlAl-negative platelet concentrate were administered, the first instance in which this treatment has been used. No rise in platelet count ensued, and the patient succumbed to purpura. Exchange transfusion or plasmapheresis remain the treatments of choice.
D000368:Aged; D000906:Antibodies; D000941:Antigens; D001777:Blood Coagulation; D001792:Blood Platelets / Q000276:immunology; D005260:Female; D006801:Humans; D017713:Platelet Transfusion; D011696:Purpura, Thrombocytopenic / Q000209:etiology*; D065227:Transfusion Reaction
D000906:Antibodies; D000941:Antigens